Non-opioid Pain SPR offers a non-opioid, minimally invasive PNS solution with a 60-day treatment window, presenting a compelling alternative for patients and payers seeking non-surgical, non-drug options for chronic pain relief.

Expansion Potential Strong regional footprint with headquarters in Cleveland and satellite offices in Chapel Hill and Minneapolis, signaling opportunities to expand sales territories and enroll more clinics and pain management centers across the Midwest and beyond.

ClinicalEvidence Largest body of clinical evidence in peripheral nerve stimulation for pain positions SPR as a credible option for payers and clinicians, enabling targeted conversations with hospitals, academic centers, and multisite pain programs.

MarketFocus Demonstrated demand in untapped peripheral (shoulder and knee) and back pain markets suggests growth opportunities by targeting specialty orthopedic clinics, physical medicine and rehabilitation (PM&R) practices, and post-operative pain pathways.

StrategicFit With revenue in the mid-range and a scalable, implant-free solution, SPR aligns with strategic partnerships, distributor channels, and hospital-based pain programs seeking innovative, first-line neuromodulation options.